Description
Book SynopsisCompletely updated and revised, the second edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents.
This simple, systematic approach defines discrete levels of psychotropics and spells out group-specific roles and responsibilities in accord with AAP policies. Plus, an included digital tool offers instant access to authoritative answers on specific conditions and medications.
Topics include
- Conceptual framework for prescribing psychotropic drugs
- Medications for specific diagnoses: ADHD, Anxiety, and Depression
- US Food and Drug Administration-Approved antipsychotics and mood stabilizers and all other medications
- What to do when treatment is unsuccessful
Trade Review“This is a useful reference for medications and therapies that help pediatric patients. The book provides important messages about assessment, prescribing, and when and how to refer.” — Sam Kohn, MD, FAAP, Asheville Children's Medical Center, NC,
Journal of the American Academy of Child & Adolescent Psychiatry, Volume 57, Number 8, August 2018
“This is an excellent resource and I am confident primary care clinicians will find it incredibly helpful in their practice. This edition contains updated guidelines and prescribing regulations and provides online access to additional resources and information.” — Maria Alcocer Alkureishi, MD, University of Chicago Pritzker School of Medicine
Table of Contents
- Introduction
- Part 1—Conceptual Framework
- Chapter 1—Conceptual Framework for Prescribing Psychotropic
- Part 2—Practical Guidance
- Chapter 2—Assessment
- Chapter 3—Prescribing Medications: Getting Started
- Part 3—Group 1 Medications for Specific Diagnoses: ADHD, Anxiety, and Depression
- Chapter 4—Group 1 Medications for Attention-Deficit/Hyperactivity Disorder
- Chapter 5—Group 1 Medications for Anxiety and Depression
- Part 4—Group 2 (FDA-Approved Antipsychotics and Mood Stabilizers) and Group 3 (All Other) Medications
- Chapter 6—Group 2 Medications: Antipsychotics and Mood Stabilizer
- Chapter 7—Group 3 Medications
- Part 5—Advanced Topics
- Chapter 8—What to Do When Treatment Is Not Successful
- Appendixes
- Index
